Targeted Treatment Shrinks Rare Brain Tumors in Small Study
THURSDAY, July 13, 2023 (HealthDay News) — A targeted treatment has had unprecedented success in shrinking a rare brain tumor, according to clinical trial results. These tumors are papillary craniopharyngiomas (PCPs), and the drug combo is called vemurafenib/cobimetinib. Each of 15 patients who received one or more cycles of targetedContinue Reading